Category
Blog
-
2023
-
Gamida Cell receives FDA approval for blood cancer therapy
-
Acadia commercialises first US Rett Syndrome drug
-
FDA Expands AbbVie’s (ABBV) Qulipta Label in Chronic Migraine
-
University of Rochester researchers discover how to steer army of immune cells toward cancer
-
Sleeping pill reduces levels of Alzheimer’s proteins
-
A gene involved in Down syndrome puts the brakes on neurons’ activity in mice, new study shows
-
Dr. Reddy’s Laboratories Announces the Launch of Treprostinil Injection in the U.S.
-
Trinity team develops promising gene therapy for glaucoma
-
Xortx Gets Orphan Drug Nod for Polycystic Kidney Disease
-
AstraZeneca and Ionis’ ATTRv-PN therapy meets trial endpoints